Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stroke Hemorrhagic: early-phase trial registry
6 of 7 indexed Stroke Hemorrhagic trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Stroke Hemorrhagic: 7 US clinical trials tracked, 6 recruiting.
Stroke Hemorrhagic is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dartmouth-Hitchcock Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition stroke-hemorrhagic
OPEN 6 | RECR 86% | LATE 0 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)
Stroke Hemorrhagic lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Stroke Hemorrhagic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Stroke Hemorrhagic is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Stroke Hemorrhagic trials is spread across many organizations.
Dartmouth-Hitchcock Medical Center accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Stroke Hemorrhagic trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Stroke Hemorrhagic research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
Emory University
NCT06870812
Ischemic Conditioning Improves Walking Function Post Stroke
Medical College of Wisconsin
NCT04038697
Utility of CC7 Transfer in Stroke Subtypes
Dartmouth-Hitchcock Medical Center
NCT06001736
Promoting Recovery After STroke With Amantadine
University of Pennsylvania
NCT05140148
The REACTplusNMES Trial: A Double-blinded RCT
University of Illinois at Chicago
NCT06127602
At-Home taVNS - Stroke Rehab
Medical University of South Carolina
NCT06616831
Behavioral Activation for Post-Stroke Sedentary Behavior Using Telehealth
University of Minnesota
NCT05029284
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Stroke Hemorrhagic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Stroke Hemorrhagic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Stroke Hemorrhagic page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Stroke Hemorrhagic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dartmouth-Hitchcock Medical Center sponsors the most Stroke Hemorrhagic trials on record, review their full trial history before evaluating a specific study. See Dartmouth-Hitchcock Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stroke Hemorrhagic condition card totals 7 registered trials; most-linked intervention teleABLE; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.